Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sarah Wiblin
Development of a T-Cell Receptor Mimic Antibody Against Wild-Type P53 for Cancer Immunotherapy
Cancer Research
Cancer Research
Oncology
Related publications
T-Cell Engineering by a Chimeric T-Cell Receptor With Antibody-Type Specificity for the HIV-1 Gp120
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
An Introduction to Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Human Cancer
American Journal of Hematology
Hematology
Hurdles of CAR-T Cell-Based Cancer Immunotherapy Directed Against Solid Tumors
Science China Life Sciences
Genetics
Molecular Biology
Environmental Science
Biochemistry
Biological Sciences
Agricultural
Chimaeric Antigen Receptor T-Cell Therapy for Tumour Immunotherapy
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Development of Next Generation Antibody-Based Immunotherapy for Childhood Cancer Neuroblastoma
The Lancet
Medicine
Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy
JAMA Oncology
Cancer Research
Oncology
CD4+ T Cell Responses to HLA-DP5-restricted Wild-Type Sequence P53 Peptides in Patients With Head and Neck Cancer
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
IL15 and T-Cell Stemness in T-Cell-Based Cancer Immunotherapy
Cancer Research
Cancer Research
Oncology
Chimeric Antigen Receptor T-Cell Immunotherapy for Glioblastoma: Practical Insights for Neurosurgeons
Neurosurgical Focus
Medicine
Surgery
Neurology